Bioadhesive properties and biodistribution of cyclodextrin-poly(anhydride) nanoparticles

被引:59
作者
Agueros, Maite [1 ]
Areses, Paloma [2 ]
Angel Campanero, Miguel [1 ]
Salman, Hesham [1 ]
Quincoces, Gemma [2 ]
Penuelas, Ivan [2 ]
Manuel Irache, Juan [1 ]
机构
[1] Univ Navarra, Dept Pharm & Pharmaceut Technol, Pamplona 31008, Spain
[2] Univ Navarra, Radiopharm Unit, Dept Nucl Med, Univ Navarra Clin, Pamplona 31008, Spain
关键词
Nanoparticles; Cyclodextrin; Bioadhesion; Gantrez (R) AN; Poly(anhydride); Oral; Tc-99m-radiostudies; BLOCK-COPOLYMER MICELLES; ORAL INSULIN DELIVERY; IMMUNOADJUVANT PROPERTIES; GASTROINTESTINAL-TRACT; PVM/MA NANOPARTICLES; BETA-CYCLODEXTRIN; LIPOPHILIC DRUGS; CARRIER SYSTEMS; QUANTIFICATION; CYCLOSPORINE;
D O I
10.1016/j.ejps.2009.02.010
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This work describes the preparation, characterization and evaluation of the nanoparticles formed by the copolymer of methyl vinyl ether and maleic anhydride (Gantrez (R) AN) and cyclodextrins. including beta-cyclodextrin (CD) hydroxypropyl-beta-cyclodextrin (HPCD) and 6-monodeoxy-6-monoamino-beta-cyclodextrin (NHCD). The cyclodextrin-poly(anhydride) nanoparticles were prepared by a solvent displacement method and characterized by measuring the size, zeta potential, morphology and composition. For bioadhesion studies. nanoparticles were fluorescently labelled with rhodamine B isothiocianate (RBITC). For in vivo imaging biodistribution studies, Tc-99m-labelled nanoparticles were used. Nanoparticles displayed a size of about 150 Full and a cyclodextrin content which was found optimal under the following experimental conditions: cyclodextrin/poly(anhydride) ratio of 0.25 by weight, 30 min of incubation time between the cyclodextrin and the polymer. Moreover, the oligosaccharide content was higher with CD than with NHCD and HPCD. Overall, cyclodextrin-poly(anhydride) nanoparticles displayed homogeneous bioadhesive interactions within the gut. The intensity of these interactions was higher than for control nanoparticles. The high bioadhesive capacity was observed for HPCD-NP and NHCD-NP which can be related with their rough morphology and, thus, a higher specific surface than for smooth nanoparticles (CD-NP). Finally, from in vivo studies, no evidence of translocation Of distribution to other organs was observed when these nanoparticles were orally administered. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:231 / 240
页数:10
相关论文
共 48 条
  • [1] Simultaneous quantification of different cyclodextrins and Gantrez by HPLC with evaporative light scattering detection
    Agüeros, M
    Campanero, MA
    Irache, JM
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2005, 39 (3-4) : 495 - 502
  • [2] Bioadhesive potential of gliadin nanoparticulate systems
    Arangoa, MA
    Ponchel, G
    Orecchioni, AM
    Renedo, MJ
    Duchêne, D
    Irache, JM
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2000, 11 (04) : 333 - 341
  • [3] Gliadin nanoparticles as carriers for the oral administration of lipophilic drugs. Relationships between bioadhesion and pharmacokinetics
    Arangoa, MA
    Campanero, MA
    Renedo, MJ
    Ponchel, G
    Irache, JM
    [J]. PHARMACEUTICAL RESEARCH, 2001, 18 (11) : 1521 - 1527
  • [4] Nanoparticles with specific bioadhesive properties to circumvent the pre-systemic degradation of fluorinated pyrimidines
    Arbós, P
    Campanero, MA
    Arangoa, MA
    Irache, JM
    [J]. JOURNAL OF CONTROLLED RELEASE, 2004, 96 (01) : 55 - 65
  • [5] Influence of the surface characteristics of PVM/MA nanoparticles on their bioadhesive properties
    Arbós, P
    Campanero, MA
    Arnangoa, MA
    Renedo, MJ
    Irache, JM
    [J]. JOURNAL OF CONTROLLED RELEASE, 2003, 89 (01) : 19 - 30
  • [6] Quantification of the bioadhesive properties of protein-coated PVM/MA nanoparticles
    Arbós, P
    Arangoa, MA
    Campanero, MA
    Irache, JM
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 242 (1-2) : 129 - 136
  • [7] Gantrez® AN as a new polymer for the preparation of ligand-nanoparticle conjugates
    Arbós, P
    Wirth, M
    Arangoa, MA
    Gabor, F
    Irache, JM
    [J]. JOURNAL OF CONTROLLED RELEASE, 2002, 83 (03) : 321 - 330
  • [8] Babu VR, 2008, EXPERT OPIN DRUG DEL, V5, P403, DOI [10.1517/17425247.5.4.403, 10.1517/17425247.5.4.403 ]
  • [9] Combined hydroxypropyl-β-cyclodextrin and poly(alkylcyanoacrylate) nanoparticles intended for oral administration of saquinavir
    Boudad, H
    Legrand, P
    Lebas, G
    Cheron, M
    Duchêne, D
    Ponchel, G
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 218 (1-2) : 113 - 124
  • [10] Drug-releasing behavior of MPEG/PLA block copolymer micelles and solid particles controlled by component block length
    Choi, SK
    Kim, D
    [J]. JOURNAL OF APPLIED POLYMER SCIENCE, 2002, 83 (02) : 435 - 445